HomeCIPLA • NSE
add
Cipla Ltd
Previous close
₹1,468.50
Day range
₹1,461.00 - ₹1,489.00
Year range
₹1,335.00 - ₹1,702.05
Market cap
1.20T INR
Avg Volume
1.68M
P/E ratio
22.73
Dividend yield
0.88%
Primary exchange
NSE
In the news
Financials
Income Statement
Revenue
Net income
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 65.98B | 6.89% |
Operating expense | 31.80B | 15.17% |
Net income | 12.22B | 30.12% |
Net profit margin | 18.52 | 21.76% |
Earnings per share | 15.12 | 30.12% |
EBITDA | 15.06B | 11.75% |
Effective tax rate | 18.70% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 80.93B | 3.81% |
Total assets | 373.87B | 14.27% |
Total liabilities | 60.98B | 3.08% |
Total equity | 312.89B | — |
Shares outstanding | 807.62M | — |
Price to book | 3.80 | — |
Return on assets | — | — |
Return on capital | 10.13% | — |
Cash Flow
Net change in cash
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 12.22B | 30.12% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Cipla Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, paediatric and various other medical conditions. Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. It is the third-largest drug producer in India. Wikipedia
CEO
Founded
1935
Headquarters
Website
Employees
27,764
